Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MURER, L.
Right arrow Articles by ZACCHELLO, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MURER, L.
Right arrow Articles by ZACCHELLO, F.
J Am Soc Nephrol 11:1132-1137, 2000
© 2000 American Society of Nephrology


REGULAR ARTICLES

Thrombotic Microangiopathy Associated with Parvovirus B 19 Infection after Renal Transplantation

LUISA MURER*, GRAZIELLA ZACCHELLO*, DANIELA BIANCHI{dagger}, ROBERTO DALL'AMICO*, GIOVANNI MONTINI*, BARBARA ANDREETTA*, MARINO PERINI{dagger}, ELISABETTA CURRÒ DOSSI*, GIANFRANCO ZANON* and FRANCO ZACCHELLO*

* Department of Pediatrics, University of Padova, Italy.
{dagger} Research and Development Department, DiaTech Srl, Jesi (An)-, Italy.

Correspondence to Dr. Luisa Murer, Department of Pediatrics, Via Giustiniani 3 35128 Padova, Italy. Phone: +39 49 8213505; Fax: +39 49 8213509; E-mail: luisam{at}child.pedi.unipd.it

Abstract. Human parvovirus B19 is considered an etiologic agent of aplastic anemia in immunosuppressed patients. Microscopic vasculitis, with or without renal involvement, has recently been attributed to this viral infection in immunocompetent patients. This study describes four cases of thrombotic renal graft microangiopathy presumably secondary to B19 infection. Twelve to 50 days after transplantation, four patients presented a renal graft dysfunction with creatinine rising to 360 to 1088 µmol/L and requiring hemodialysis in three cases. Renal involvement appeared after a systemic illness characterized by fever, fatigue and arthralgia, aplastic anemia (hemoglobin ranged from 5.3 to 7.8 g/dl), and thrombocytopenia. A thrombotic microangiopathy was observed in the renal biopsies, and the parvovirus B19 genome was isolated by PCR from the specimens. All four patients also became IgM-positive for parvovirus. Three of the four renal biopsies taken at the time of transplantation (T0) from the same patients were found positive for the B19 genome. Graft function recovered, with resolution of the aplastic anemia, within 22 to 110 d. Twenty biopsies performed as routine controls or for suspected acute rejection and nine T0 biopsies of patients with no signs of B19 infection were used. The B19 genome was found in two of 20 posttransplant biopsies and in one of nine T0 biopsies. The temporal association between aplastic anemia and the onset of thrombotic graft microangiopathy, isolation of the viral genome in renal specimens, seroconversion, and endothelial tropism of the virus suggests that B19 could be the etiologic agent of thrombotic microangiopathy in these cases. The development of the disease after infection could depend on other detrimental cofactors, which make the patient more susceptible to microthrombi formation in the renal microvasculature. The renal graft could represent the route of B19 transmission.




This article has been cited by other articles:


Home page
CJASNHome page
N. Leca, K. A. Muczynski, J. A. Jefferson, I. H. de Boer, J. Kowalewska, E. A. Kendrick, R. Pichler, and C. L. Davis
Higher Levels of Leflunomide Are Associated with Hemolysis and Are not Superior to Lower Levels for BK Virus Clearance in Renal Transplant Patients
Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 829 - 835.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
M. Waldman and J. B. Kopp
Parvovirus B19 and the Kidney
Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(Supplement_1): S47 - S56.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
H. Nishi, N. Hanafusa, Y. Kondo, M. Nangaku, Y. Sugawara, M. Makuuchi, E. Noiri, and T. Fujita
Clinical Outcome of Thrombotic Microangiopathy after Living-Donor Liver Transplantation Treated with Plasma Exchange Therapy
Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 811 - 819.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C. M. Wyatt, S. Dikman, V. Sehgal, B. T. Murphy, J. S. Bromberg, S. Ames, and E. Akalin
Chronic organizing microangiopathy in a renal transplant recipient
Nephrol. Dial. Transplant., August 1, 2005; 20(8): 1734 - 1737.
[Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
E. D. Heegaard and K. E. Brown
Human Parvovirus B19
Clin. Microbiol. Rev., July 1, 2002; 15(3): 485 - 505.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP